 |
 |
|||||
  |
 |
 |
 |
 |
 |
|
 |
|
|
FKH pioneered the use of science-based communications to help biotech companies build their visibility, credibility and value. We know how to extract maximum opportunity from conference presentations, journal publications and clinical and regulatory milestones — trial recruitment, publication of Phase II and III data, FDA filings, Advisory Committee meetings. Our team of biotech experts offers a full range of strategy and support:
|
|
||
 |
||||
|
|
|
|
|